USD
Intact-Mass Testing vs Peptide Mapping: Different Questions, Different Evidence
Short answer: intact-mass testing asks whether the whole measured analyte has a mass consistent with expectation. Peptide mapping examines a pattern of smaller fragments after controlled cleavage. Both can contribute to identity work, but they answer different questions and should not be presented as equivalent evidence.
Start with the question, not the acronym
Analytical records are easier to assess when the method is linked to its intended purpose. Intact-mass testing can provide a fast whole-molecule comparison. Peptide mapping can add localized structural information by comparing a fragment pattern against an expected map. Neither label tells a reader enough without the method context and the sample-to-batch connection.
| Method | Primary analytical question | Useful record details |
|---|---|---|
| Intact mass | Is the whole-analyte mass consistent with expectation? | Observed and expected mass, tolerance, charge state, reference or calculation. |
| Peptide mapping | Does the fragment pattern align with an expected structural map? | Cleavage conditions, monitored fragments, chromatogram or spectra, comparison criteria. |
| HPLC purity | How was detectable signal distributed in one separation? | Column, detection, integration, chromatogram, and peak rules. |
Why the distinction matters
A dominant intact-mass signal does not automatically show every sequence feature. Conversely, a peptide map is not a substitute for a purity measurement or a net-content result. The appropriate evidence depends on the claim being evaluated and the limitations of the procedure.
The USP discussion of synthetic peptide reference standards describes using multiple analytical approaches to address identity, purity, and related attributes. Its lesson for record review is simple: do not expand a result beyond the question that method was designed to answer.
How to compare two reports fairly
- Confirm both reports identify the same material and batch.
- Write down the claim each method is meant to support.
- Compare method details, not only pass/fail wording.
- Flag missing method conditions or missing reference information.
- Keep identity evidence, impurity evidence, and microbiological fields in separate columns.
Use NOVABIO’s Lab Results & COA page to locate a batch record where available. Read what a peptide mass match can and cannot confirm for the whole-molecule evidence boundary.
To apply the comparison to a catalog record, begin at the NOVABIO research catalog, browse Growth & Signaling, and use the CJC-1295 with DAC catalog page only to match displayed identity fields with available documentation.
Limits of this guide
This is a high-level explanation of method purpose, not a validation protocol or an assessment of a specific material. It does not establish sequence, purity, or quality for a NOVABIO product or batch.